v3.26.3
Fair Value Measurements - Narratives (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 9 Months Ended
Feb. 28, 2026
USD ($)
shares
Feb. 23, 2026
USD ($)
shares
Jan. 07, 2025
USD ($)
shares
Jan. 07, 2024
USD ($)
$ / shares
shares
Aug. 31, 2026
USD ($)
shares
Feb. 28, 2026
USD ($)
Feb. 28, 2024
shares
Sep. 30, 2026
USD ($)
$ / shares
Sep. 30, 2025
USD ($)
Aug. 30, 2026
$ / shares
Dec. 31, 2025
USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]                      
Purchases of equity investments               $ 1,000 $ 1,250    
Convertible Notes | Convertible Debt                      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]                      
Loan payable               $ 15,500      
Debt instrument, interest rate (percent)               5.00%      
Debt instrument, convertible, conversion price (in USD per share) | $ / shares               $ 1,125      
Precision License Agreement | Precision BioSciences, Inc.                      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]                      
Reverse stock splits (in shares) | shares             30        
License agreement, trading days           30 days          
Precision License Agreement | Precision BioSciences, Inc.                      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]                      
License agreement, amount paid upfront   $ 7,500   $ 7,500   $ 7,500          
License agreement, amount paid upfront, cash $ 5,250 5,250   5,250   5,250          
License agreement, amount paid upfront, equity investment $ 2,250 $ 2,250   $ 2,250   $ 2,250          
Investment owned, balance (in shares) | shares 201,504 201,504 220,712 2,920,816              
Investment purchased balance price per share (in USD per share) | $ / shares       $ 0.77              
Purchases of equity investments     $ 2,500                
License agreement, payment, percentage of weighted average share price 2 2 2     2          
License agreement, trading days   30 days 30 days 30 days              
Equity investments, fair value disclosure     $ 1,400               $ 800
Imugene Subscription Agreement | Imugene Limited                      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]                      
License agreement, amount paid upfront         $ 1,000            
Investment owned, balance (in shares) | shares         15,789,474            
Investment purchased balance price per share (in USD per share) | $ / shares                   $ 0.095